Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study

被引：0
|
作者：
Felix Hasler
Ulrike Grimberg
Marco A. Benz
Theo Huber
Franz X. Vollenweider
机构：
[1] Psychiatric University Hospital Zürich,Heffter Research Center
来源：
Psychopharmacology | 2004年 / 172卷
关键词：
Psilocybin; Dose–effect study; Psycho(patho)logy; Neuroendocrinology; Cardiovascular effects; Altered states of consciousness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：145 / 156
页数：11
相关论文
共 39 条
  • [1] Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
    Hasler, F
    Grimberg, U
    Benz, MA
    Huber, T
    Vollenweider, FX
    PSYCHOPHARMACOLOGY, 2004, 172 (02) : 145 - 156
  • [2] Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
    Klaiber, Aaron
    Schmid, Yasmin
    Becker, Anna M.
    Straumann, Isabelle
    Erne, Livio
    Jelusic, Alen
    Thomann, Jan
    Luethi, Dino
    Liechti, Matthias E.
    TRANSLATIONAL PSYCHIATRY, 2024, 14 (01):
  • [3] Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
    Holze, Friederike
    Vizeli, Patrick
    Ley, Laura
    Mueller, Felix
    Dolder, Patrick
    Stocker, Melanie
    Duthaler, Urs
    Varghese, Nimmy
    Eckert, Anne
    Borgwardt, Stefan
    Liechti, Matthias E.
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (03) : 537 - 544
  • [4] Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers Results of an experimental double-blind placebo-controlled studyResults of an experimental double-blind placebo-controlled study
    E. Gouzoulis-Mayfrank
    B. Thelen
    E. Habermeyer
    H. J. Kunert
    K.-A. Kovar
    H. Lindenblatt
    L. Hermle
    M. Spitzer
    H. Sass
    Psychopharmacology, 1999, 142 : 41 - 50
  • [5] Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants
    Straumann, Isabelle
    Ley, Laura
    Holze, Friederike
    Becker, Anna M.
    Klaiber, Aaron
    Wey, Kathrin
    Duthaler, Urs
    Varghese, Nimmy
    Eckert, Anne
    Liechti, Matthias E.
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 (13) : 1840 - 1848
  • [6] Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial
    von Rotz, Robin
    Schindowski, Eva M.
    Jungwirth, Johannes
    Schuldt, Anna
    Rieser, Nathalie M.
    Zahoranszky, Katharina
    Seifritz, Erich
    Nowak, Albina
    Nowak, Peter
    Jaencke, Lutz
    Preller, Katrin H.
    Vollenweider, Franz X.
    ECLINICALMEDICINE, 2023, 56
  • [7] Metyrapone and cocaine: A double-blind, placebo-controlled drug interaction study
    Winhusen, T
    Somoza, E
    Haffer, JM
    Moore, E
    Ussery, T
    Kropp, F
    Singal, B
    Elkashef, A
    Mojsiak, J
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 80 (04) : 631 - 638
  • [8] Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG
    Euphrosyne Gouzoulis-Mayfrank
    Mathias Schreckenberger
    Osama Sabri
    Christoph Arning
    Bernhard Thelen
    Manfred Spitzer
    Karl-Artur Kovar
    Leopold Hermle
    Udalrich Büll
    Henning Sass
    Neuropsychopharmacology, 1999, 20 : 565 - 581
  • [9] Psilocybin Administration to Healthy Participants: Safety and Feasibility in a Placebo-Controlled Study
    Rucker, James
    Young, Allan
    Williams, Samuel
    Stansfield, Susan
    Eriksson, Hans
    Malievskaia, Ekaterina
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 443 - 444
  • [10] Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers -: A double-blind, placebo-controlled PET study with [18F]FDG
    Gouzoulis-Mayfrank, E
    Schreckenberger, M
    Sabri, O
    Arning, C
    Thelen, B
    Spitzer, M
    Kovar, KA
    Hermle, L
    Büll, U
    Sass, H
    NEUROPSYCHOPHARMACOLOGY, 1999, 20 (06) : 565 - 581
1234